Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetyl-CoA carboxylase (ACC) is a biotin-dependent enzyme (EC 6.4.1.2) that catalyzes the irreversible carboxylation of acetyl-CoA to form malonyl-CoA, which is the first and rate-limiting step in fatty acid synthesis. This reaction plays a central role in lipid metabolism by providing malonyl-CoA for fatty acid biosynthesis and regulating fatty acid oxidation. There are two main isoforms in mammals: ACC1 (ACCα) and ACC2 (ACCβ). ACC1 is primarily expressed in lipogenic tissues and involved in de novo lipogenesis, while ACC2 is mainly found in oxidative tissues and regulates mitochondrial fatty acid β-oxidation. The enzyme is regulated allosterically and via phosphorylation.
Inhibition of acetyl-CoA carboxylase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetyl-CoA Carboxylase (ACC).